New analysis from Frost & Sullivan finds that the European telemedicine market generated revenues of $118.0 million in 2007 and is estimated to reach $236.0 million by 2014.
Strategic Analysis: Competitive Benchmarking of Telemedicine Vendors in Europe describes how, although the European telemedicine industry has achieved significant progress, certain technological advances have inadvertently led to new hurdles.
These include the greater need for standards and physician acceptance of novel telemedicine technologies.
“While it is apparent that the telemedicine industry is in the midst of great change, it is not clear how the industry will look in the years to come,” states Frost & Sullivan Research Analyst Janani Narasimhan. “Technological developments have the potential to not only alleviate the current growing pains but also provide some solutions for the major challenges facing the business of telemedicine delivery.”
The industry’s technology is becoming increasingly sophisticated and powerful. At the same time, prices for computers, software and transmission equipment are falling.
Many market participants are looking to lower the cost of technologies to widen the deployment of telemedicine, while health organisations are increasingly using telehealth technology to monitor patients remotely. However, the lack of payer reimbursement is a major barrier to broader adoption. Moreover, the technology is believed to be extremely expensive, with questionable returns on investment.
Governments will be compelled to adopt certain eHealth strategies accompanied by concrete actions, if they wish to keep pace with future demands for healthcare and reduce escalating healthcare costs. As the number of households connected to the Internet grows, the number of web sites/portals dedicated to patients with specific diseases will expand as well. This trend will also increase online communication between doctors and patients, auguring well for market expansion.
